Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |